DE60319989D1 - Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande - Google Patents

Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande

Info

Publication number
DE60319989D1
DE60319989D1 DE60319989T DE60319989T DE60319989D1 DE 60319989 D1 DE60319989 D1 DE 60319989D1 DE 60319989 T DE60319989 T DE 60319989T DE 60319989 T DE60319989 T DE 60319989T DE 60319989 D1 DE60319989 D1 DE 60319989D1
Authority
DE
Germany
Prior art keywords
opioid receptor
receptor ligands
diazabicylononane
decanderivate
diazabicyclononane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60319989T
Other languages
English (en)
Other versions
DE60319989T2 (de
Inventor
Dan Peters
Gunnar M Olsen
Elsebet Oestergaard Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Application granted granted Critical
Publication of DE60319989D1 publication Critical patent/DE60319989D1/de
Publication of DE60319989T2 publication Critical patent/DE60319989T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60319989T 2002-07-26 2003-07-24 Diazabicyclononan - und decanderivate und ihre verwendung als opioid-rezeptorligande Expired - Lifetime DE60319989T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201143 2002-07-26
DK200201143 2002-07-26
PCT/DK2003/000510 WO2004011468A1 (en) 2002-07-26 2003-07-24 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands

Publications (2)

Publication Number Publication Date
DE60319989D1 true DE60319989D1 (de) 2008-05-08
DE60319989T2 DE60319989T2 (de) 2008-07-17

Family

ID=30775758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60319989T Expired - Lifetime DE60319989T2 (de) 2002-07-26 2003-07-24 Diazabicyclononan - und decanderivate und ihre verwendung als opioid-rezeptorligande

Country Status (12)

Country Link
US (1) US7358243B2 (de)
EP (1) EP1527075B1 (de)
JP (1) JP4588444B2 (de)
CN (1) CN100340561C (de)
AT (1) ATE390427T1 (de)
AU (1) AU2003280306B2 (de)
CA (1) CA2489165A1 (de)
DE (1) DE60319989T2 (de)
HK (1) HK1077827A1 (de)
MX (1) MXPA05001002A (de)
NZ (1) NZ537182A (de)
WO (1) WO2004011468A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040954A1 (it) * 2004-05-12 2004-08-12 Univ Degli Studi Milano Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
EP2149370A1 (de) * 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabizyclischen Verbindungen und Mikroemulsionen, dieselben enthaltend
IT1390848B1 (it) 2008-07-31 2011-10-19 Neuroscienze Pharmaness S C A R L Composti farmaceutici
IT1395452B1 (it) * 2009-02-25 2012-09-21 Neuroscienze Pharmaness S C A Rl Microemulsioni
IT1390850B1 (it) * 2008-07-31 2011-10-19 Neuroscienze Pharmaness S C A R L Microemulsioni
IT1394400B1 (it) 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
EP2789619A1 (de) 2013-04-12 2014-10-15 Kemotech S.r.l. Pharmazeutische Verbindungen mit angiogenesehemmender Wirkung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274018B (it) * 1994-02-23 1997-07-14 Riace Ets Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
EP1177196B1 (de) * 1999-05-04 2004-03-10 Neurosearch A/S Heteroaryl diazabicycloalkene, deren herstellung und verwendung
IT1317841B1 (it) * 2000-02-18 2003-07-15 Univ Degli Studi Milano Derivati del 3,9-diazabiciclo(3.3.1)nonano ad attivita' analgesica.
AU2001249250A1 (en) 2000-03-29 2001-10-08 Research Triangle Institute Selective ligands for the delta opioid receptor

Also Published As

Publication number Publication date
AU2003280306B2 (en) 2009-05-21
HK1077827A1 (en) 2006-02-24
EP1527075A1 (de) 2005-05-04
DE60319989T2 (de) 2008-07-17
JP4588444B2 (ja) 2010-12-01
US7358243B2 (en) 2008-04-15
CA2489165A1 (en) 2004-02-05
NZ537182A (en) 2006-07-28
CN1668621A (zh) 2005-09-14
US20050239773A1 (en) 2005-10-27
AU2003280306A1 (en) 2004-02-16
WO2004011468A1 (en) 2004-02-05
MXPA05001002A (es) 2005-05-16
CN100340561C (zh) 2007-10-03
JP2005536522A (ja) 2005-12-02
EP1527075B1 (de) 2008-03-26
ATE390427T1 (de) 2008-04-15

Similar Documents

Publication Publication Date Title
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
ATE438633T1 (de) Benzo (d) isoxazol-3-yl-amin- verbindungen und deren verwendung als vanilloid-rezeptor liganden
DE60228487D1 (de) Ethylenediaminderivate und ihre verwendung als orexinrezeptorantagonisten
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
ATE472547T1 (de) Kondensierte n-heterozyclische verbindungen und ihre verwendung als crf-rezeptor antagonisten.
GB0115862D0 (en) Compounds
DE60316012D1 (de) Purinderivate und ihre verwendung als liganden des cannabinoid rezeptors
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
DE50210986D1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre verwendung als adenosinrezeptor-selektive liganden
ATE446753T1 (de) Verwendung von substituierten 2-thio-3,5-dicyano- 4-phenyl-6-aminopyridinen bei der behandlung von übelkeit und erbrechen
PT1877364E (pt) Derivados fenilacetileno com afinidade para o receptor mglur5
HK1077827A1 (en) Diazabicyclononane and-decane derivatives their use as opioid receptor ligands
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
DE60327375D1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
NO20060603L (no) Fremgangsmate for fremstillingen av fenyltetrazolderivater
DE10108995A1 (de) Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren
WO2003042234A3 (en) Non-peptide somatostatin receptor ligands
ATE411301T1 (de) Diphenylurea-derivative und ihre verwendung als chloridkanalblocker
DE602004030231D1 (de) Pyrimidinonverbindungen als calcilytica
DE602004009583D1 (de) Piperidin- oder 8-azabicycloä3.2.1üoct-3-ylderivate, die sich als modulatoren der chemokinrezeptoraktivität eignen
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
DE60311000D1 (de) Indolderivate und deren verwendung als 5-ht liganden
DE602004018324D1 (de) Steroid modifizierte solatriosen
PT1909792E (pt) Derivados substituídos da piperidina como antagonistas do receptor sst1 da somatostatina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition